Archive for the ‘Pharmaeconomics Consultations’ Category

Practical Law Guide to Orphan Drug Act (June 2016)

Legislative History The Orphan Drug Act, 21 U.S.C. § 360cc(a), was enacted in 1983 to foster the development of drugs—called orphan drugs—to treat rare diseases or conditions that affect fewer than 200,000 people.  These drugs were “orphaned,” because the comparatively small demand for treatment for any rare disease left pharmaceutical firms with little incentive to […]

Cancer Treatment About Face, Again by Hiyaguha Cohen

Tags: Breast Cancer Alternative Cancer Treatments Cancer Chemotherapy Throughout history, various medical cures have become popular in spite of the fact that at first glance many people might think they were, in fact, barbaric. For instance, the Mayans and Incans favored trepanation, a process in which a person who suffered seizures or migraines had holes […]

Meet the Robin Hood of Science

http://bigthink.com/neurobonkers/a-pirate-bay-for-science?utm_source=pocket&utm_medium=email&utm_campaign=pockethits

Chiropractor in Stage 4 Cancer, Weeks to Live, Able to Cure Himself

Recommended Blood Tests for Preventive Check Ups

Recommended Blood Tests for Preventive Check Ups Last week, I completed my twice per year comprehensive set of blood tests. It might be informative to compare my tests with the set of tests that you normally get for a preventive check up on your overall health. Here are the tests that I received

Health Economics and Outcomes Research Medical Unit Medical Resource Management

Here is the scope of work of one of our consulting assignments. The project involved streamlining and optimizing HEOR personnel deployed in a therapeutic area by a large pharmaceutical firm. Provide expertise/strategic leadership of key initiatives within the US General Medicine and Health Economics and Outcomes Research (HEOR) functions Responsible to provide direction, oversight and […]

Immunotherapy: Using the Immune System to Treat Cancer

Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor.

Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Source: National Institute of Allergy and Infectious Diseases (NIAID). The immune system’s natural capacity to detect and destroy abnormal cells may prevent the development of many cancers. However, some cancers are able to avoid […]

Clinical Trial Finds Moderate Cooling Improves Transplant Results

http://blog.fisherbioservices.com/two-and-a-half-degrees-of-separation-clinical-trial-finds-moderate-cooling-improves-transplant-results

Global Value Dossiers (GVD)

Michael has worked on global value dossiers (GVD) for pipeline and marketed pharmaceuticals as well as medical devices in the cardiac surgery and wound healing space.  These value dossiers reflect detailed assessment of payer reimbursement levels, value propositions in terms of net savings to the payers, and competitive market assessments.  Normally, Michael is tasked as […]

New drug delivery technologies seek to advance personalized oncology treatments

  Ongoing research on two new drug delivery systems could help clinicians more accurately understand how certain tumors react to different treatments, according to the Journal of the American Medical Association … Read Novartis to assess biologics with micro-sugar-needle delivery tech Novartis has partnered with Google-backed Rani Therapeutics to assess an oral platform which delivers […]